These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3611)

  • 1. Immunology of DNA. I. The influence of reaction conditions on the Farr assay as used for the detection of anti-ds DNA.
    Aarden LA; Lakmaker F; Feltkamp TE
    J Immunol Methods; 1976; 10(1):27-37. PubMed ID: 3611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of pH on the detection of low- and high-avidity anti-dsDNA.
    Smeenk R; Duin T; Aarden L
    J Immunol Methods; 1982 Dec; 55(3):361-73. PubMed ID: 6187861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Determination of anti dsDNA antibodies by immunofluorescence using Crithidia luciliae. I--Diagnostic and prognostic value in systemic lupus erythematosus. Comparison with the Farr radioimmunoassay].
    Borda-Iriarte O; Meyer O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 Apr; 51(4):185-91. PubMed ID: 6374861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of anti-nDNA antibodies in ANA-positive systemic lupus erythematosus: comparison of the Farr radioimmunoassay and the Crithidia luciliae immunofluorescent technique.
    Chuan MT; Wu YC; Ang ET; Wang JH; In KL; Lü YC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1985 Feb; 18(1):15-24. PubMed ID: 3896689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrepancies between two procedures for ds-DNA antibody detection: Farr test and indirect immunofluorescence on Crithidia luciliae.
    Monier JC; Sault C; Veysseyre C; Bringuier JP
    J Clin Lab Immunol; 1988 Mar; 25(3):149-52. PubMed ID: 3294417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microplate ELISA for detection of antibodies to DNA in patients with systemic lupus erythematosus: specificity and correlation with Farr radioimmunoassay.
    Sutjita M; Hohmann A; Boey ML; Bradley J
    J Clin Lab Anal; 1989; 3(1):34-40. PubMed ID: 2715873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunology of DNA. IV. Quantitative aspects of the Farr assay.
    Aarden LA; Lakmaker F; De Groot ER
    J Immunol Methods; 1976; 11(2):153-63. PubMed ID: 932447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity in systemic lupus erythematosus of antibodies to double-stranded DNA measured with the polyethylene glycol precipitation assay.
    Smeenk R; van der Lelij G; Swaak T; Groenwold J; Aarden L
    Arthritis Rheum; 1982 Jun; 25(6):631-8. PubMed ID: 7092963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of molecular weight of DNA on the determination of anti-DNA antibodies in systemic lupus erythematosus (SLE) sera by radioimmunoassay.
    Geisert M; Heicke B; Metzmann E; Zahn RK
    Nucleic Acids Res; 1975 Apr; 2(4):521-35. PubMed ID: 1138235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of commercial kits for the detection of antibodies to double-stranded DNA.
    Adams LE; Grant KD; Hess EV
    Am J Clin Pathol; 1982 Jan; 77(1):54-9. PubMed ID: 6976755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the Farr assay to the analysis of antibodies specific for UV irradiated DNA.
    Strickland PT; Boyle JM
    J Immunol Methods; 1981; 41(1):115-24. PubMed ID: 7021682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA used to assay sera for anti-DNA antibodies; determination of the specificities of anti-DNA antibodies in SLE and non-SLE rheumatic disease states.
    Locker JD; Medof ME; Bennett RM; Sukhupunyaraksa S
    J Immunol; 1977 Feb; 118(2):694-701. PubMed ID: 300090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Absence of anti double stranded DNA antibodies in viral hepatitis (author's transl)].
    Monier JC; Perraud M; Chevallier PH; Sepetjan M; Trepo C
    Nouv Presse Med; 1979 Jun; 8(29):2395-8. PubMed ID: 493025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay.
    Arden LA; Lakmaker F; Feltkamp TE
    J Immunol Methods; 1976; 10(1):39-48. PubMed ID: 1082911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement fixing antibodies to DS-DNA in systemic lupus erythematosus: a study using the immunofluorescent Crithidia luciliae method.
    Beaulieu A; Quismorio FP; kitridou RC; Friou GJ
    J Rheumatol; 1979; 6(4):389-96. PubMed ID: 392093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of anti-double stranded DNA antibodies of IgG, IgA and IgM classes by ELISA. Comparison with the Farr test and indirect immunofluorescence].
    Preud'homme JL; Danon F; Rochard E; Gouet D; Touchard G; Aucouturier P; Alcalay M
    Presse Med; 1988 Jul 9-16; 17(27):1401-4. PubMed ID: 2971167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between dissociation and inhibition of association of DNA/anti-DNA complexes.
    Smeenk RJ; Aarden LA; van Oss CJ
    Immunol Commun; 1983; 12(2):177-88. PubMed ID: 6874000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levels of anti-nDNA using immunofluorescence on Crithidia luciliae. II. Prognostic value of complement-fixing anti-nDNA. Longitudinal study of 16 lupus disorders].
    Meyer O; Borda-Iriarte O; Cyna J; Haïm T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):243-9. PubMed ID: 6377460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to native DNA: detection by immunoperoxidase assay and determination of their immunoglobulin classes.
    Vladutiu AO; Palumbo DA; Asirwatham JE
    Clin Chem; 1979 Mar; 25(3):366-70. PubMed ID: 400438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.